# Abraxis Bioscience, LLC - Inspection Records

Source: https://www.keypedia.com/companies/abraxis-bioscience-llc/5751a531-276f-4635-9289-30cacf498d86

> Inspection records and compliance data for Abraxis Bioscience, LLC in Phoenix, Arizona. Access full analysis and detailed observations.

---

## Details

- Name: Abraxis Bioscience, LLC
- FEI Number: 3006441852
- City: Phoenix
- State: Arizona
- Country Name: United States
- Address Line 1: 620 N 51st Ave
- Zip Code: 85043

## Related Documents

- [483 - Abraxis Bioscience, LLC - 2023-10-06](https://www.keypedia.com/records/483/abraxis-bioscience-llc/aa826ec4-8ed3-4488-80ea-38b12127d3a0) — source: FDA, date: October 6, 2023
- [FDA Inspection 1220002 - Abraxis Bioscience, LLC - 2023-10-06](https://www.keypedia.com/records/fda_inspections/abraxis-bioscience-llc/58116093-0aaf-4761-95a0-a780c7719f06) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 6, 2023
- [483 - Abraxis Bioscience, LLC - 2022-04-06](https://www.keypedia.com/records/483/abraxis-bioscience-llc/250f83a6-29ae-4dc6-98ec-9e1f3087c8a8) — source: FDA, date: April 6, 2022
- [FDA Inspection 1166508 - Abraxis Bioscience, LLC - 2022-04-06](https://www.keypedia.com/records/fda_inspections/abraxis-bioscience-llc/17dedab2-0d44-4c20-8a3a-2b3820d76f39) — classification: Official Action Indicated (OAI), source: FDA, date: April 6, 2022
- [483 - Abraxis Bioscience, LLC - 2020-02-19](https://www.keypedia.com/records/483/abraxis-bioscience-llc/56322b10-4097-43ef-b961-9927ed0e18e9) — source: FDA, date: February 19, 2020
- [FDA Inspection 1118264 - Abraxis Bioscience, LLC - 2020-02-19](https://www.keypedia.com/records/fda_inspections/abraxis-bioscience-llc/83c095aa-ddce-4552-a2b5-1812a54e44cd) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 19, 2020
- [FDA Inspection 1062643 - Abraxis Bioscience, LLC - 2018-08-17](https://www.keypedia.com/records/fda_inspections/abraxis-bioscience-llc/4a9fc8a1-2388-43bc-9f2e-6f88696e8fd3) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 17, 2018
- [FDA Inspection 987449 - Abraxis Bioscience, LLC - 2016-06-24](https://www.keypedia.com/records/fda_inspections/abraxis-bioscience-llc/bdfe78fc-b849-4a70-8f74-4a716d265e0c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 24, 2016
- [FDA Inspection 890300 - Abraxis Bioscience, LLC - 2014-08-08](https://www.keypedia.com/records/fda_inspections/abraxis-bioscience-llc/233e437a-ec07-41ae-9257-03bffb6ff828) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 8, 2014
- [FDA Inspection 848727 - Abraxis Bioscience, LLC - 2013-09-16](https://www.keypedia.com/records/fda_inspections/abraxis-bioscience-llc/89dbcc5a-b6d0-49a4-a733-bb790952e785) — classification: No Action Indicated (NAI), source: FDA, date: September 16, 2013
- [FDA Inspection 785920 - Abraxis Bioscience, LLC - 2012-06-08](https://www.keypedia.com/records/fda_inspections/abraxis-bioscience-llc/d17ab237-d7bf-47e9-8f36-273526eb8ca8) — classification: No Action Indicated (NAI), source: FDA, date: June 8, 2012
- [FDA Inspection 679215 - Abraxis Bioscience, LLC - 2010-09-02](https://www.keypedia.com/records/fda_inspections/abraxis-bioscience-llc/59f17885-c152-4f07-908b-68f6578df98e) — classification: No Action Indicated (NAI), source: FDA, date: September 2, 2010
- [FDA Inspection 610731 - Abraxis Bioscience, LLC - 2009-09-04](https://www.keypedia.com/records/fda_inspections/abraxis-bioscience-llc/00cbdd0f-f238-486b-a35b-afe02f118929) — classification: No Action Indicated (NAI), source: FDA, date: September 4, 2009

## Related Companies

- [Catalent Pharma Solutions, LLC](https://www.keypedia.com/companies/catalent-pharma-solutions-llc/12f42026-6a34-4cfe-936d-3646a0e34c8d)
- [Lyne Laboratories, Inc.](https://www.keypedia.com/companies/lyne-laboratories-inc/47a79cbe-dd2e-43d9-bf70-129caae3817c)
- [DPT Laboratories, Ltd](https://www.keypedia.com/companies/dpt-laboratories-ltd/0a6b4d0a-ad7e-4f4f-ab10-34e0ef9913d4)
- [Catalent CTS, LLC](https://www.keypedia.com/companies/catalent-cts-llc/db17ec22-68a4-42be-86e9-4c1410a493a8)
- [Ultradent Products, Inc.](https://www.keypedia.com/companies/ultradent-products-inc/16b4d8af-54bd-48d3-acc8-a5169bd5bfe3)
- [Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company](https://www.keypedia.com/companies/bristol-myers-squibb-holdings-pharma-ltd-liability-company/64a65e7b-7328-491c-8b08-cc8f2e018968)
- [Bushu Pharmaceuticals Ltd.](https://www.keypedia.com/companies/bushu-pharmaceuticals-ltd/f3ccab51-b6fa-4873-b2de-61ba32d7967e)
- [Laboratorios Liconsa SAU](https://www.keypedia.com/companies/laboratorios-liconsa-sau/ab88a2bb-8c52-445d-8417-82ea8f48bdf6)
- [WES Pharma Inc.](https://www.keypedia.com/companies/wes-pharma-inc/26195242-bcfc-4382-817b-4d9d153b962d)
- [AMO (Hangzhou) Co., Ltd.](https://www.keypedia.com/companies/amo-hangzhou-co-ltd/00c065f6-3b50-4050-811e-d03ad3d646e9)

## Related Officers

- [Carrie A. Hughes](https://www.keypedia.com/people/carrie-a-hughes/099d1128-0ba9-4e7a-a0d2-8c10083811c9)
- [Microbiologist](https://www.keypedia.com/people/michael-t-cyrus/30e497e1-2c17-4dd7-9a5b-251771cf4266)
- [Lesley R Gutierrez](https://www.keypedia.com/people/lesley-r-gutierrez/e3fc8a5b-99c4-4456-b69a-6b881f3e6790)
- [Senior CSO, Investigator](https://www.keypedia.com/people/nicholas-l-hunt/2f10c080-c02e-4cc3-a8a0-0675b9c4cc6d)